跳至主要内容
临床试验/NCT04414020
NCT04414020Unknown1 期

Cytoprotective Effect and Clinical Outcome of Perioperative Proesterone in Brain Tumors

Minia University1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2020年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
26
试验地点
1
主要终点
Number of Participants With craniotomy-Related Adverse Events

研究概览

简要总结

Neuronal injury is evident in elective craniotomy for space occupying lesions. Surgical trauma and mechanichal impact of the tumor causes neuronal injury. Neurosreroid progesterone is a neurotransmittern , trail to use in abolishing neurotoxcicty

详细描述

Progesterone is a natural neurosteroid that we are trying to use to impede both direct neuronal injury cauesd by and indirectly by surgical trauma. Progesterone can decreas vasogenic brain oedema. Our primary outcome is to ameliorate microscopic cytoplasmic injury and decrease brain oedema exploited by biopsy from brain tumor interface. Exclusion criteria demonstratd as refusal to participate in the trial , emergency craniotomy, recurrent brain tumor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All elective brain tumors elligible for craniotomy

排除标准

  • Refusal to participare
  • Emergency craniotomy

研究组 & 干预措施

progesterone group

Active Comparator

1mg pregesterone intramusculer given 7 days pre and post operative , Biopsy was achieved from brain tumor interface

干预措施: Progesteron (Drug)

结局指标

主要结局

Number of Participants With craniotomy-Related Adverse Events

时间窗: 3 months

Degree of microscopic cellular injury and brain odema in brain biopsy

次要结局

  • Number of Participants with neuronal deficit(2 months)

研究者

发起方
Minia University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mina Maher

Principle investigator

Ministry of Health and Population, Egypt

研究点 (1)

Loading locations...

相似试验